Study of Humidified Air to Improve Mucociliary Clearance (MCC) in COPD
Sponsor: Fisher and Paykel Healthcare
A NA clinical study on COPD, this trial is completed. The trial is conducted by Fisher and Paykel Healthcare and has accumulated 11 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
-
Feb 2023 — Jul 2023 [monthly]
Completed NA
Status: Recruiting → Completed
-
Feb 2022 — Feb 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2022 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Sep 2020 [monthly]
Recruiting NA
-
Sep 2019 — Feb 2020 [monthly]
Recruiting NA
-
Aug 2019 — Sep 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fisher and Paykel Healthcare
- Frank C Sciurba
For direct contact, visit the study record on ClinicalTrials.gov .